Carregant...
Cholesterol Efflux Capacity, Macrophage Reverse Cholesterol Transport, and Cardioprotective HDL
PURPOSE OF REVIEW: Randomized clinical trials provide strong evidence that pharmacological elevation of HDL-cholesterol (HDL-C) fails to reduce cardiovascular disease risk in statin-treated humans. It is thus critical to identify new metrics that capture HDL's cardioprotective effects. RECENT F...
Guardat en:
| Publicat a: | Curr Opin Lipidol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4617325/ https://ncbi.nlm.nih.gov/pubmed/26270810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOL.0000000000000209 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|